2025 annual financial data
MiNK Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -12,487,304 USD and net income was -12,494,260 USD.
Operating cash flow was -5,925,168 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,487,304 USD
- Net income
- -12,494,260 USD
- Operating cash flow
- -5,925,168 USD